BACKGROUND: Epidemiologic studies have suggested that environmental factors and diet are important risk factors in the pathogenesis of prostate cancer. The N-acetyltransferases (NAT) are important enzymes in activation and inactivation of various carcinogens, including those found in well-cooked meat and cigarette smoke. METHODS: We analyzed DNA samples from 146 prostate cancer patients and 174 healthy men. We used PCR-RFLP method to analyze NAT 1 and NAT 2 polymorphisms. RESULTS: We did not find statistically significant differences in NAT 1 genotypes frequencies between prostate cancer patients and control group. We observed an association of the slow acetylator genotype, NAT 2*6/NAT2*6 with prostate cancer protection (P=0.017; OR=0.31, 95% CI 0.11--0.84). Multivariate logistic regression analysis confirmed this association (0.030; OR=0.32, 95% CI 0.12--0.89). CONCLUSIONS: Our results indicate a role of NAT2 polymorphisms in the carcinogenic pathway of prostate cancer, specifically in a population of Southern Europe. (c) 2005 Wiley-Liss, Inc.
BACKGROUND: Epidemiologic studies have suggested that environmental factors and diet are important risk factors in the pathogenesis of prostate cancer. The N-acetyltransferases (NAT) are important enzymes in activation and inactivation of various carcinogens, including those found in well-cooked meat and cigarette smoke. METHODS: We analyzed DNA samples from 146 prostate cancerpatients and 174 healthy men. We used PCR-RFLP method to analyze NAT 1 and NAT 2 polymorphisms. RESULTS: We did not find statistically significant differences in NAT 1 genotypes frequencies between prostate cancerpatients and control group. We observed an association of the slow acetylator genotype, NAT 2*6/NAT2*6 with prostate cancer protection (P=0.017; OR=0.31, 95% CI 0.11--0.84). Multivariate logistic regression analysis confirmed this association (0.030; OR=0.32, 95% CI 0.12--0.89). CONCLUSIONS: Our results indicate a role of NAT2 polymorphisms in the carcinogenic pathway of prostate cancer, specifically in a population of Southern Europe. (c) 2005 Wiley-Liss, Inc.
Authors: Marta Vilčková; Jana Jurečeková; Dušan Dobrota; Viera Habalová; Lucia Klimčáková; Iveta Waczulíková; Peter Slezák; Ján Kliment; Monika Kmeťová Sivoňová Journal: Med Oncol Date: 2014-05-11 Impact factor: 3.064
Authors: Mario Maciel de Lima Junior; Leonardo Oliveira Reis; Ana Carolina Trindade Guilhen; Fabiana Granja; Mariana Nicolau de Lima Oliveira; Ubirajara Ferreira; Lucas Leite Cunha; Laura Sterian Ward Journal: Med Oncol Date: 2012-01-14 Impact factor: 3.064
Authors: Sangita Sharma; Xia Cao; Lynne R Wilkens; Jennifer Yamamoto; Annette Lum-Jones; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-06-22 Impact factor: 4.254
Authors: Taro Iguchi; Shozo Sugita; Ching Y Wang; Nancy B Newman; Tatsuya Nakatani; Gabriel P Haas Journal: In Vivo Date: 2009 Jan-Feb Impact factor: 2.155
Authors: La Creis Renee Kidd; Tiva T Vancleave; Mark A Doll; Daya S Srivastava; Brandon Thacker; Oyeyemi Komolafe; Vasyl Pihur; Guy N Brock; David W Hein Journal: Biomark Cancer Date: 2011-02-03